MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis

• Yanhui Zhang ^[1] ; Jing Wang ^[1] ; Yuqin Fan ^[1] ; Fangfang Lang ^[1] ; Fengping Fu ^[1] ; Qunying Liu ^[1]
  1. [1] Shandong Province Maternal and Child Health Care Hospital Afliated to Qingdao University, Jinan City, China
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 26, Nº. 3, 2024, págs. 653-663
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Background Matrix metalloproteinases (MMP) are important proteases that degrade the extracellular matrix (ECM) and thus essentially mediate tumor vascularization, metastasis, and invasion. However, their potential roles in uterine corpus endometrial carcinoma (UCEC) are not fully understood.

    Patients and methods The expression, prognostic value, and correlation of UCEC patients with MMP were investigated using data from The Cancer Genome Atlas (TCGA) and other databases. Furthermore, differentially expressed genes (DEGs) were identified and their biological functions and correlations with infiltrating immune cells were analyzed.

    Results A total of 22 MMPs were found to be abnormally expressed in UCEC tumor tissues, and high expression of MMP11 and MMP17 were associated with a better UCEC prognosis. MMP11 and MMP17 were observed to be significantly enriched in tumor tissue ECM and were associated with pathways involving degradation, glycolytic metabolism, and PI3K-Akt signaling. Infiltration of natural killer (NK), mast, and NK CD56bright cells was enhanced in tumor tissues with high MMP11 and MMP17 expression.

    Conclusion MMP11 and MMP17 may affect UCEC prognosis by influencing immune cell infiltration and may be potential UCEC biomarkers.